GlassScriptPhysician profile
Ludwik K Branski
NPI 1821323163
$6,348.77
in general payments reported to CMS, 2019-2025
16 companies · $365 in 2025
The $365 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $17.81 · 2021: $109 · 2022: $250 · 2023: $490 · 2024: $4,642 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $1,938 · Travel and Lodging: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $1,938.44 |
| Travel and Lodging | $558.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $4,083.66 | 2023-2025 | Novosorb Btm |
| Kerecis Limited | $667.74 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Musculoskeletal Transplant Foundation INC. | $342.56 | 2024 | |
| Integra Lifesciences Corporation | $260.26 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Coopersurgical, INC. | $206.37 | 2019-2025 | Cook, Onetrac Lx |
| Sientra, INC. | $131.13 | 2022 | |
| Baxter Healthcare | $108.69 | 2019 | |
| Zimmer Biomet Holdings, INC. | $99.96 | 2019 | |
| Alafair Biosciences, INC. | $95.78 | 2025 | Versawrap |
| Smith+Nephew, INC. | $88.28 | 2022-2023 | Renasys Go V2 Home, Pico |
| Medline Industries LP | $83.48 | 2019-2022 | |
| Axogen | $77.34 | 2019 | |
| Polymedics Innovations INC. | $48.54 | 2022 | |
| Abbvie INC. | $34.41 | 2024 | |
| Acera Surgical, INC. | $20.57 | 2023 | Restrata Wound Matrix |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ludwik Branski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.